Read on Twitter
“Our trial will not demonstrate prevention of transmission, because in order to do that you have to swab people twice a week for very long periods, and that becomes operationally untenable.” Tal Zaks, chief medical officer at Moderna. /1 https://twitter.com/CrasTalk/status/1338618215673556994
"None of the leading vaccine candidate trials is designed to test if the vaccine can reduce severe COVID-19 symptoms, defined as: hospital admissions, ICU or death." /2
"And, second, the trials are not designed to test if the vaccine can interrupt transmission" /3 https://www.bmj.com/content/bmj/371/bmj.m4037.full.pdf
"If neither of these conditions is met, the vaccine in essence performs like a therapeutic drug, except a vaccine would be taken prophylactically, even by the perfectly healthy, and more than likely carries a higher risk of injury than a therapeutic drug." /4
"If this were to be true, then therapeutic drugs would be superior to any COVID vaccine." /5 https://www.scribd.com/document/487135032/Wodarg-Yeadon-EMA-Petition-Pfizer-Trial-FINAL-01DEC2020-en-Unsigned-With-Exhibits
